Table of Contents
Asian Journal of Neuroscience
Volume 2014 (2014), Article ID 649106, 6 pages
http://dx.doi.org/10.1155/2014/649106
Research Article

Role of Interleukin-6 Correlated to C. pneumoniae Infection as a Biomarker for Prediction of Stroke Severity in Young Patients with Acute Ischemic Stroke

1Department of Neurology, AIIMS, New Delhi, India
2Department of Microbiology, AIIMS, New Delhi, India
3Department of Neuro-Biochemistry, AIIMS, New Delhi, India

Received 18 January 2014; Revised 3 June 2014; Accepted 29 June 2014; Published 20 July 2014

Academic Editor: Taku Sugawara

Copyright © 2014 M. V. Padma Srivastava et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. M. Dalal, “Strokes in young and elderly: risk factors and strategies for stroke prevention,” Journal of Association of Physicians of India, vol. 45, no. 2, pp. 125–131, 1997. View at Google Scholar · View at Scopus
  2. T. K. Banerjee and S. K. Das, “Epidemiology of stroke in India,” Neurology Asia, vol. 11, pp. 1–4, 2006. View at Google Scholar
  3. M. S. V. Elkind, M. L. C. Tondella, D. R. Feikin, B. S. Fields, S. Homma, and M. R. Di Tullio, “Seropositivity to Chlamydia pneumoniae is associated with risk of first ischemic stroke,” Stroke, vol. 37, no. 3, pp. 790–795, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Abraham, P. S. Rao, S. G. Inbaraj, G. Shetty, and C. J. Jose, “An epidemiological study of hemiplegia due to stroke in South India.,” Stroke, vol. 1, no. 6, pp. 477–481, 1970. View at Publisher · View at Google Scholar · View at Scopus
  5. T. K. Banerjee, C. S. Mukherjee, and A. Sarkhel, “Stroke in the urban population of Calcutta: an epidemiological study,” Neuroepidemiology, vol. 20, no. 3, pp. 201–207, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Virok, Z. Kis, L. Karai et al., “Chlamydia pneumoniae in atherosclerotic middle cerebral artery,” Stroke, vol. 32, no. 9, pp. 1973–1976, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. M. V. Kalayoglu, P. Libby, and G. I. Byrne, “Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease,” Journal of the American Medical Association, vol. 288, no. 21, pp. 2724–2731, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. G. K. Hansson, “Mechanisms of disease: inflammation, atherosclerosis, and coronary artery disease,” The New England Journal of Medicine, vol. 352, no. 16, pp. 1626–1695, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. P. M. Ridker, C. H. Hennekens, J. E. Buring, R. Kundsin, and J. Shih, “Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women,” Annals of Internal Medicine, vol. 131, no. 8, pp. 573–577, 1999. View at Google Scholar · View at Scopus
  10. R. Cosentini and F. Blasi, “New pathogens for respiratory infections,” Current Opinion in Pulmonary Medicine, vol. 2, no. 3, pp. 174–180, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. U. Waje-Andreassen, J. Kråkenes, E. Ulvestad et al., “IL-6: an early marker for outcome in acute ischemic stroke,” Acta Neurologica Scandinavica, vol. 111, no. 6, pp. 360–365, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Perini, M. Morra, M. Alecci, E. Galloni, M. Marchi, and V. Toso, “Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients,” Neurological Sciences, vol. 22, no. 4, pp. 289–296, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. M. A. Mendall, P. M. Goggin, N. Molineaux et al., “Relation of Helicobacter pylori infection and coronary heart disease,” British Heart Journal, vol. 71, no. 5, pp. 437–439, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. P. J. Cook, D. Honeybourne, G. Y. H. Lip, D. G. Beevers, R. Wise, and P. Davies, “Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham stroke project,” Stroke, vol. 29, no. 2, pp. 404–410, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Leinonen, “Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae,” European Heart Journal, vol. 14, pp. 57–61, 1993. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Jin, G. Yang, and G. Li, “Inflammatory mechanisms in ischemic stroke: role of inflammatory cells,” Journal of Leukocyte Biology, vol. 87, no. 5, pp. 779–789, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. N. K. Rai, R. Choudhary, R. Bhatia et al., “Chlamydia pneumoniae seropositivity in adults with acute ischemic stroke: a case-control study,” Annals of Indian Academy of Neurology, vol. 14, no. 2, pp. 93–97, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Sonobe, J. Liang, S. Jin et al., “Microglia express a functional receptor for interleukin-23,” Biochemical and Biophysical Research Communications, vol. 370, no. 1, pp. 129–133, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Becher, B. G. Durell, and R. J. Noelle, “IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis,” Journal of Clinical Investigation, vol. 112, no. 8, pp. 1186–1191, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. E. H. Lo, “Experimental models, neurovascular mechanisms and translational issues in stroke research,” British Journal of Pharmacology, vol. 153, supplement 1, pp. S396–S405, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Gertz, G. Kronenberg, R. E. Kälin et al., “Essential role of interleukin-6 in post-stroke angiogenesis,” Brain, vol. 135, no. 6, pp. 1964–1980, 2012. View at Publisher · View at Google Scholar
  22. Y. Maeda, M. Matsumoto, O. Hori et al., “Hypoxia/reoxygenation-mediated induction of astrocyte interleukin 6: a paracrine mechanism potentially enhancing neuron survival,” Journal of Experimental Medicine, vol. 180, no. 6, pp. 2297–2308, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Suzuki, K. Tanaka, S. Nogawa et al., “Temporal profile and cellular localization of interleukin-6 protein after focal cerebral ischemia in rats,” Journal of Cerebral Blood Flow and Metabolism, vol. 19, no. 11, pp. 1256–1262, 1999. View at Google Scholar · View at Scopus
  24. I. Gueorguieva, S. R. Clark, C. J. McMahon et al., “Pharmacokinetic modeling of interleukin- 1 receptor antagonist in plasma and cerebrospinal fluid of patients following subarachnoid hemorrhage,” British Journal of Clinical Pharmacology, vol. 65, no. 3, pp. 317–325, 2008. View at Google Scholar · View at Scopus
  25. D. Acalovschi, T. Wiest, M. Hartmann et al., “Multiple levels of regulation of the interleukin-6 system in stroke,” Stroke, vol. 34, no. 8, pp. 1864–1869, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Madre, J. L. Garcia, R. C. Gonzalez et al., “Association between seropositivity to Chlamydia pneumoniae and acute ischaemic stroke,” European Journal of Neurology, vol. 9, no. 3, pp. 303–306, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. S. L. Melnick, E. Shahar, A. R. Folsom et al., “Past infection by Chlamydia pneumoniae strain and asymptomatic carotid atherosclerosis,” The American Journal of Medicine, vol. 95, no. 5, pp. 499–504, 1993. View at Publisher · View at Google Scholar · View at Scopus
  28. S. L. Stevens, J. Bao, J. Hollis, N. S. Lessov, W. M. Clark, and M. P. Stenzel-Poore, “The use of flow cytometry to evaluate temporal changes in inflammatory cells following focal cerebral ischemia in mice,” Brain Research, vol. 932, no. 1-2, pp. 110–119, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. D. L. Hahn, T. Anttila, and P. Saikku, “Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma,” Epidemiology and Infection, vol. 117, no. 3, pp. 513–517, 1996. View at Publisher · View at Google Scholar · View at Scopus
  30. C. J. Smith, H. C. A. Emsley, C. M. Gavin et al., “Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome,” BMC Neurology, vol. 4, article 5, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. M. V. Kalayoglu, P. Libby, and G. I. Byrne, “Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease,” Journal of the American Medical Association, vol. 288, no. 21, pp. 2724–2731, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Saikku, K. Mattila, M. S. Nieminen et al., “Serological evidence of an association of a novel chlamydia, with chronic coronary heart disease and acute myocardial infarction,” The Lancet, vol. 2, no. 8618, pp. 983–986, 1988. View at Google Scholar · View at Scopus
  33. S. Pelidou, N. Kostulas, D. Matusevicius, P. Kivisäkk, V. Kostulas, and H. Link, “High levels of IL-10 secreting cells are present in blood in cerebrovascular diseases,” European Journal of Neurology, vol. 6, no. 4, pp. 437–442, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. V. C. S. S. Bandaru, V. Laxmi, M. Neeraja et al., “Chlamydia pneumoniae antibodies in various subtypes of ischemic stroke in Indian patients,” Journal of the Neurological Sciences, vol. 272, no. 1-2, pp. 115–122, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. M. S. V. Elkind, I. F. Lin, J. T. Grayston, and R. L. Sacco, “Chlamydia pneumoniae and the risk of first ischemic stroke: the northern manhattan stroke study,” Stroke, vol. 31, no. 7, pp. 1521–1525, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Tarkowski, L. Rosengren, C. Blomstrand et al., “Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke,” Stroke, vol. 26, no. 8, pp. 1393–1398, 1995. View at Publisher · View at Google Scholar · View at Scopus
  37. J. S. Kim, S. S. Yoon, Y. H. Kim, and J. S. Ryu, “Serial measurement of interleukin-6, transforming growth factor-β, and S-100 protein in patients with acute stroke,” Stroke, vol. 27, no. 9, pp. 1553–1557, 1996. View at Publisher · View at Google Scholar · View at Scopus
  38. W. Whiteley, C. Jackson, S. Lewis et al., “Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6,” PLoS Medicine, vol. 6, no. 9, Article ID e1000145, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Castillo and I. Rodríguez, “Biochemical changes and inflammatory response as markers for brain ischaemia: molecular markers of diagnostic utility and prognosis in human clinical practice,” Cerebrovascular Diseases, vol. 17, supplement 1, pp. 7–18, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Vila, J. Castillo, A. Dávalos, A. Esteve, A. M. Planas, and Á. Chamorro, “Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke,” Stroke, vol. 34, no. 3, pp. 671–675, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. P. J. Martin, T. V. Enevoldson, and P. R. Humphrey, “Causes of ischemic stroke in young,” Postgraduate Medical Journal, vol. 73, no. 855, pp. 8–16, 1997. View at Google Scholar
  42. G. Yilmaz and D. N. Granger, “Cell adhesion molecules and ischemic stroke,” Neurological Research, vol. 30, no. 8, pp. 783–793, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Vila, J. Castillo, A. Dávalos, and Á. Chamorro, “Proinflammatory cytokines and early neurological worsening in ischemic stroke,” Stroke, vol. 31, no. 10, pp. 2325–2329, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Ngeh, S. Gupta, C. Goodbourn, B. Panayiotou, and G. McElligott, “Chlamydia pneumoniae in elderly patients with stroke (C-PEPS): a case-control study on the seroprevalence of Chlamydia pneumoniae in elderly patients with acute cerebrovascular disease,” Cerebrovascular Diseases, vol. 15, no. 1-2, pp. 11–16, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Yamashita, K. Ouchi, M. Shirai, T. Gondo, T. Nakazawa, and H. Ito, “Distribution of Chlamydia pneumoniae infection in the atherosclerotic carotid artery,” Stroke, vol. 29, no. 4, pp. 773–778, 1998. View at Publisher · View at Google Scholar · View at Scopus